BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17094915)

  • 1. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
    Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
    Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
    Sakaeda T; Yamamori M; Kuwahara A; Hiroe S; Nakamura T; Okumura K; Okuno T; Miki I; Chayahara N; Okamura N; Tamura T
    Ther Drug Monit; 2008 Aug; 30(4):497-503. PubMed ID: 18641541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
    Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
    Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
    Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
    Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local failure-related factors of esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Liu H; Li QQ; Cai L; Huang Y; Lin HX; Wang HY; Liu H; Cui NJ
    Ai Zheng; 2005 Apr; 24(4):498-501. PubMed ID: 15820078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
    Futami R; Tajiri T; Miyashita M; Maruyama H; Makino H; Nomura T; Tateno A; Miyashita T; Sasajima K
    Gan To Kagaku Ryoho; 2003 May; 30(5):681-4. PubMed ID: 12795101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
    BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil--a phase II study.
    Fuwa N; Shikama N; Hayashi N; Matsuzuka T; Toita T; Yuta A; Oonishi H; Kodaira T; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Oct; 43(9):948-55. PubMed ID: 17257880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 22 cases of esophageal adenosquamous carcinoma].
    Zhang DK; Su XD; Lin P; Long H; Fu JH; Zhang LJ; Ma GW; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):302-4. PubMed ID: 19615289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
    Chen XY; Li JS; Liang QP; He DZ; Zhao J
    Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.